Can Tirzepatide Make You Tired?

Is tiredness on tirzepatide actually common?

Fatigue shows up consistently enough in tirzepatide data that it earned a place in the medicine's official labelling. The SURMOUNT-1 trial, which ran for 72 weeks across thousands of adults with obesity, reported fatigue among the side effects seen at higher rates in the tirzepatide groups than in placebo. The NHS medicines information for tirzepatide lists it as a side effect that affects up to one in ten people. That framing is worth sitting with: it is not the most common effect (nausea, diarrhoea and indigestion rank higher), but it is common enough that you are not imagining it if it hits you.

The short answer on whether tirzepatide makes you feel unwell in the early weeks is that a cluster of symptoms, tiredness included, is fairly typical in the adjustment period. The question worth asking is whether your fatigue fits the pattern or sits outside it.

Tiredness that arrives in the first day or two after an injection, softens by mid-week, then repeats when the next dose goes in is usually adjustment fatigue. Tiredness that builds steadily over weeks, does not ease between injections, or arrives alongside other symptoms deserves a conversation with your prescriber sooner rather than later.

Why does tirzepatide cause fatigue — the mechanism

Tirzepatide works by activating both GIP and GLP-1 receptors, two pathways involved in appetite regulation and blood-sugar control. Slowing gastric emptying is central to how it reduces hunger, but that same slowing means nutrients are absorbed more gradually. During dose increases especially, your body is adapting to a new energy rhythm at the same time as eating less. That combination, lower calorie intake plus a gut that is working differently, is the most plausible driver of early fatigue for most people.

There is also the nausea factor. If you are waking up feeling queasy, you may be sleeping less well, eating less than your body needs, or both. Poor sleep and undernutrition both feed tiredness. The deeper look at why tirzepatide causes fatigue covers the GIP/GLP-1 mechanism in more detail if you want the physiology unpacked further.

One practical note worth flagging: if you keep your pen in the fridge door (2–8°C, which is where it should be stored), it takes only a moment to check that you are also keeping a protein-forward breakfast on the radar. Protein and hydration are two factors our prescribers most often raise when patients report fatigue in the first month.

The decision: push through, adjust your routine, or contact your prescriber

This is the question most people arrive at after a few weeks: is this normal tiredness that will pass, or is it a signal to do something differently? The answer depends on a few factors.

Mild fatigue in the days after an injection, especially at 2.5mg or at your first dose step up, sits within the expected range. Keeping well hydrated, eating enough protein (even when appetite is low), and moving gently rather than hard training tend to make it more manageable. Our full side effects overview for Mounjaro sets the broader context, including GI effects and injection-site reactions, so you can see how tiredness fits alongside the rest.

If fatigue is affecting your ability to work, drive, or care for others, or if it has lasted more than two to three weeks at a stable dose, that crosses into territory that needs clinical review. A prescriber can check whether there is something else contributing, whether your dose timing is right, or whether a slower titration would suit you better. People who want to understand how long tirzepatide tiredness typically lasts often find that having a timeline helps them calibrate whether to wait or escalate.

You can also read about the combination of feeling cold and tired on Mounjaro, which sometimes reflects a drop in overall calorie availability rather than the medicine itself.

What the prescriber considers, and how nume fits in

Wait, that should read nume. At nume, every treatment plan is reviewed before each repeat order by a GPhC-registered Independent Prescriber. A real clinician reads your consultation, not software. Fatigue reports in our aftercare channel are responded to seven days a week, so if something feels off mid-cycle you have somewhere to take it.

Tirzepatide is a Prescription-Only Medicine. Suitability depends on your health history, current medicines, and BMI, among other things, a prescriber draws on all of that before recommending it. If you are weighing up the cost of Mounjaro treatment alongside the question of whether side effects like fatigue are manageable for you, our prescribers are well placed to talk that through during a consultation.

You can also explore the weight-loss treatment options we offer more broadly, or read about how Mounjaro works as a starting point. The NHS tirzepatide medicines page and the MHRA Yellow Card scheme are also worth bookmarking: Yellow Card lets you report side effects directly to the regulator, and doing so contributes to the ongoing safety monitoring of newer medicines like this one.

If you are ready to speak to a prescriber about whether tirzepatide is right for you, start your free consultation, it takes a few minutes, and you'll have a clinical answer the same day.